Working… Menu
Trial record 1 of 1 for:    GAIN/iCAT2
Previous Study | Return to List | Next Study

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02520713
Recruitment Status : Recruiting
First Posted : August 13, 2015
Last Update Posted : May 11, 2021
Information provided by (Responsible Party):
Katherine A. Janeway, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : July 2024